Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer

Published:2015-11 Issue:11 Volume:10 Page:1625-1633
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Khullar Onkar V.,Liu Yuan,Gillespie Theresa,Higgins Kristin A.,Ramalingam Suresh,Lipscomb Joseph,Fernandez Felix G

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington;Chest,2013

2. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group;Ginsberg;Ann Thorac Surg,1995

3. Population variations in the initial treatment of non-small-cell lung cancer;Potosky;J Clin Oncol,2004

4. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?;Okada;Ann Thorac Surg,2001

5. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer;Koike;J Thorac Cardiovasc Surg,2003

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Sublobar Resection in Early-Stage Non-Small-Cell Lung Cancer;Journal of Clinical Medicine;2024-09-05

2. Is Lobectomy Actually Worse Than Segmentectomy for All Stage I Non-Small Cell Lung Cancer?;Journal of Surgical Research;2024-08

3. Benefits of adjuvant chemotherapy in elderly patients with stage IB–IIIB non-small cell lung cancer: a propensity-matched analysis;Translational Cancer Research;2024-06

4. Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma—Takeaways From Modern Randomized Trials;The Annals of Thoracic Surgery;2024-05

5. Development and validation of a deep learning signature for predicting lymphovascular invasion and survival outcomes in clinical stage IA lung adenocarcinoma: A multicenter retrospective cohort study;Translational Oncology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3